Related Experiment Videos
Migraine treatment: the British perspective
1City of London Migraine Clinic.
Headache
|September 1, 1994
Summary
Migraine affects 10% of the population, with diagnosis relying on patient history and physical exams. Effective treatments focus on managing individual attacks using medication and rest.
Area of Science:
- Neurology
- Epidemiology
Background:
- Migraine impacts approximately 10% of the population in the US and UK.
- Patient complexity and expectations vary between the US and UK.
- Treatment approaches differ, with the UK favoring single formulations and avoiding barbiturates for migraine.
Purpose of the Study:
- To outline the diagnostic criteria for migraine.
- To discuss current therapeutic strategies for migraine management.
Main Methods:
- Diagnosis is primarily based on patient history and the exclusion of other physical causes.
- Investigations are used to rule out alternative headache etiologies, not to confirm migraine.
- Treatment focuses on managing individual migraine attacks.
Main Results:
- Most migraine sufferers experience fewer than four attacks per month.
- Effective attack therapies have been developed over the last two decades.
- Key treatments include sleep, anti-nausea medication, analgesics, ergotamine, and sumatriptan.
Conclusions:
- Accurate diagnosis is paramount for effective migraine treatment.
- Current management emphasizes symptom relief during attacks.
- Advancements in pharmacotherapy, such as sumatriptan, have improved attack management.